YouthBio Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
YouthBio Therapeutics General Information
Description
Developer of partial cellular reprogramming gene therapies designed to restore youthful gene expression in targeted cells for therapeutic benefits. The company specializes in tissue-specific gene therapies, aiming to rejuvenate key organ systems with an initial focus on the brain, enabling the treatment of brain diseases like Alzheimer's by promoting cellular rejuvenation in neurons and other brain cell types.
Contact Information
Website
youthbiotx.comCorporate Office
- Seattle, WA
- United States
Corporate Office
- Seattle, WA
- United States
YouthBio Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-May-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 26-Jul-2023 | Completed | Generating Revenue |
YouthBio Therapeutics Comparisons
Industry
Financing
Details
YouthBio Therapeutics Competitors (6)
One of YouthBio Therapeutics’s 6 competitors is Rejuvenate Bio, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Rejuvenate Bio | Venture Capital-Backed | San Diego, CA | ||||
| Shift Bioscience | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Retro | Venture Capital-Backed | San Francisco, CA | ||||
| Calico | Venture Capital-Backed | San Francisco, CA | ||||
| Life Biosciences | Venture Capital-Backed | Boston, MA |
YouthBio Therapeutics Patents
YouthBio Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024364256-A1 | Brain-cell specific partial cellular reprogramming treatment and prevention methods for alzheimer's disease and progeria, compositions therefore, and uses thereof | Pending | 18-Oct-2023 | ||
| EP-4794736-A1 | Brain-cell specific partial cellular reprogramming treatment and prevention methods for alzheimer's disease and progeria, compositions therefore, and uses thereof | Pending | 18-Oct-2023 | ||
| WO-2025085704-A1 | Brain-cell specific partial cellular reprogramming treatment and prevention methods for alzheimer's disease and progeria, compositions therefore, and uses thereof | Inactive | 18-Oct-2023 | C12N15/86 |
YouthBio Therapeutics Signals
YouthBio Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Westcott Industries | Family Office | Minority | ||
| MassChallenge | Accelerator/Incubator |
YouthBio Therapeutics FAQs
-
When was YouthBio Therapeutics founded?
YouthBio Therapeutics was founded in 2020.
-
Where is YouthBio Therapeutics headquartered?
YouthBio Therapeutics is headquartered in Seattle, WA.
-
What is the size of YouthBio Therapeutics?
YouthBio Therapeutics has 3 total employees.
-
What industry is YouthBio Therapeutics in?
YouthBio Therapeutics’s primary industry is Drug Discovery.
-
Is YouthBio Therapeutics a private or public company?
YouthBio Therapeutics is a Private company.
-
What is YouthBio Therapeutics’s current revenue?
The current revenue for YouthBio Therapeutics is .
-
Who are YouthBio Therapeutics’s investors?
Westcott Industries and MassChallenge have invested in YouthBio Therapeutics.
-
Who are YouthBio Therapeutics’s competitors?
Rejuvenate Bio, Shift Bioscience, Retro, Calico, and Life Biosciences are some of the 6 competitors of YouthBio Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process